Endocrinology News This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 16.

Diabetes diagnosis more likely in lower-income groups
A new diagnosis of diabetes is more likely in lower-income groups than in higher ones, new research shows. And the impact of income is greater in younger vs older age groups.
Source: theHeart.org - January 16, 2013 Category: Cardiology Source Type: news

New Meta-Analysis on Sugar Sparks Old DebateNew Meta-Analysis on Sugar Sparks Old Debate
A meta-analysis showing that consumption of sugar increases body weight supports growing calls for tighter recommendations on intake; sugar-sweetened drinks are a particular culprit, as are refined carbohydrates, says an accompanying editorial. Heartwire
Source: Medscape Today Headlines - January 16, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Drugs for diabetes? Scientists test the power of plants
Scientists believe they have identified potential sources of medicines derived from plants which may have fewer adverse side-effects for diabetes sufferers.
Source: ScienceDaily Headlines - January 16, 2013 Category: Science Source Type: news

Health Tip: Get Regular Care to Manage Diabetes
Factors to check at each doctor's visit Source: HealthDay Related MedlinePlus Page: Diabetes
Source: MedlinePlus Health News - January 16, 2013 Category: Consumer Health News Source Type: news

Media workshop for early-career researchers at Newcastle University
Early career researchers at Newcastle University wishing to gain skills in science communication may be interested in the following opportunity. The Voice of Young Science (VoYS) network, run by science advocacy group Sense About Science, is putting on a workshop to help early-career researchers engage with the public debate on science, supported by Newcastle University. As an annual supporter of VoYS we encourage any eligible SfE members based at Newcastle University and their post-docs and PhD students to apply to attend by the deadline of 8 February. Please see the link to the VoYS website below for more information.F...
Source: Society for Endocrinology - January 16, 2013 Category: Endocrinology Source Type: news

Migraines are the second biggest risk factor for women suffering a heart attack or stroke
Migraines with visual disturbances, known as aura, were a bigger risk factor than diabetes, smoking, obesity and family history, according to the American Academy of Neurology study.
Source: the Mail online | Health - January 16, 2013 Category: Consumer Health News Source Type: news

Raft of new drugs approved in Scotland
New drugs for diabetes and infection control are among those given the green light for use in Scotland by the NHS.
Source: Nursing Times Breaking News - January 16, 2013 Category: Nursing Source Type: news

Software Reveals New Clues To Degenerative Diseases
An effort to develop software that unravels the complexities of how proteins fold is paying dividends in new findings on how they misfold, according to researchers at Rice University. The study published this week in the Proceedings of the National Academy of Sciences by chemist Peter Wolynes and his team at Rice's BioScience Research Collaborative should be of particular interest to those who probe the roots of degenerative diseases associated with the aggregation of amyloid fibers in the body. These include Alzheimer's and Parkinson's diseases and Type 2 diabetes...
Source: Health News from Medical News Today - January 16, 2013 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Health Tip: Get Regular Care to Manage Diabetes
Title: Health Tip: Get Regular Care to Manage DiabetesCategory: Health NewsCreated: 1/16/2013 8:35:00 AMLast Editorial Review: 1/16/2013 12:00:00 AM
Source: MedicineNet Diabetes General - January 16, 2013 Category: Endocrinology Source Type: news

Diabulimia is 'a growing problem'
A leading doctor says diabulimia - when people with diabetes restrict their insulin to lose weight - is a growing problem specifically in young women.
Source: BBC News | Health | UK Edition - January 16, 2013 Category: Consumer Health News Source Type: news

New drug pricing regime ‘unacceptably’ slow
NICE guidance need not be mandatory – says select committeeRelated items from OnMedicaGP pay for diabetes ‘must be reviewed’Push for more genetic testing on the NHSHome births safe and cost-effective for low-risk womenNICE reveals proposed new QOF targetsDoctors should take ‘TripAdvisor’ style info seriously
Source: OnMedica Latest News - January 16, 2013 Category: UK Health Source Type: news

The Adenosine A2B Receptor and Diabetic GlomerulopathyThe Adenosine A2B Receptor and Diabetic Glomerulopathy
This animal study explores the pathogenic role of the adenosine A2B receptor in mediating early stages of renal dysfunction in diabetic nephropathy. Could this be a target for intervention? Laboratory Investigation
Source: Medscape Today Headlines - January 15, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Scottish Medicines Consortium issues guidance for use of Forxiga as type two diabetes therapy
Scottish Medicines Consortium (SMC) has issued advice that enables NHS Boards to allow physicians to prescribe Forxiga (dapagliflozin) as first-in-class type 2 diabetes treatment.
Source: Drug Development Technology - January 15, 2013 Category: Pharmaceuticals Source Type: news

Twitter Helps People Lose Weight
January 15, 2013 (Newswise) — A study by researchers at the University of South Carolina's Arnold School of Public Health has found that using Twitter, the popular information network joining people throughout the world, is a valuable support system for helping people lose weight. read more
Source: Diabetes News from dLife.com - January 15, 2013 Category: Consumer Health News Authors: dlife Source Type: news

Will Alkermes' Antipsychotic ALKS-3831 Become Another Tredaptive?
Second generation antipsychotic drugs, which were first discovered and developed in the 1990s, have been remarkably successful from a medical and commercial standpoint. One of the first, olanzepine (sold by Lilly as Zyprexa), had peak sales exceeding $5 billion before losing its patent protection in 2010. However, while effective in treating schizophrenia, olanzepine can cause dramatic weight gain in patients - a major problem in keeping patients on therapy as this weight gain can predispose patients to type 2 diabetes.
Source: Forbes.com Healthcare News - January 15, 2013 Category: Pharmaceuticals Authors: John LaMattina Source Type: news

Medical News You May Have Missed (Week of Jan. 14)
The FDA requires reductions in recommended doses of zolpidem; update on the flu; new BP goals for patients with diabetes; selective use of D-Dimer for suspected DVT; new food safety standards. . . here: 5 quick summaries of medical news headlines with links out to original sources.
Source: Consultant Live - January 15, 2013 Category: Primary Care Source Type: news

Breast cancer drug tamoxifen recommended for 'high risk' women (BBC News Online, 15 January 2013)
The National Institute for Health and Clinical Excellence (NICE) has launched a consultation on using the breast cancer drug tamoxifen as a preventative medicine in women with a family history of breast cancer. Full article
Source: Society for Endocrinology - January 15, 2013 Category: Endocrinology Source Type: news

Analysis: Drug industry bets on new blockbusters in 2013
LONDON/NEW YORK (Reuters) - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12 months.
Source: Reuters: Health - January 15, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

GSK Announces Regulatory Submission Of Its Type 2 Diabetes Drug Albigultide
GlaxoSmithKline has announced a regulatory submission to the U.S. Food and Drug Administration for its type 2 diabetes drug called albigultide. The drug, which is taken once-weekly, is a a glucagon-like peptide-1 agonist (GLP-1 agonist). The peptide GLP-1 promotes insulin production which is vital for stabilizing blood sugar levels after a meal - those with diabetes aren't able to properly secrete this peptide. Normal insulin production is restored among diabetics by taking Albiglutide, which contains two modified human copies of GLP-1 - enabling a longer duration of action...
Source: Health News from Medical News Today - January 15, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Why Down Syndrome Increases Susceptibility To Alzheimer's Disease, Diabetes And Autistic Spectrum Disorders
A study led by UC Irvine researchers has revealed some of the underlying neural factors that explain why people with Down syndrome are more susceptible to Alzheimer's disease, diabetes and autistic spectrum disorders. Jorge Busciglio, associate professor of neurobiology & behavior, and colleagues analyzed the cellular and molecular mechanisms leading to oxidative stress and mitochondrial dysfunction in Down syndrome individuals. They found that this breakdown in energy metabolism within brain cells contributes to the higher probability of these other conditions...
Source: Health News from Medical News Today - January 15, 2013 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Research Likely To Improve Drugs Used To Fight Cancer, Diabetes And Other Diseases
Even when at rest, the human body is a flurry of activity. Like a microscopic metropolis locked in a state of perpetual rush hour traffic, the trillions of cells that make us who we are work feverishly policing the streets, making repairs, building new structures and delivering important cargo throughout the bustling organic society. For everything to work properly there must be something to organize and direct the various workers. Enter protein kinases...
Source: Health News from Medical News Today - January 15, 2013 Category: Consumer Health News Tags: Biology / Biochemistry Source Type: news

Vitamin D not only prevents chronic diseases, but also extends natural lifespan
Vitamin D has been hailed for its unique ability to dramatically lower the risk of many forms of cancer, and has been shown to lower the risk of heart disease, diabetes, stroke and dementia. As these chronic diseases combine to be the leading causes of death for the...
Source: NaturalNews.com - January 15, 2013 Category: Consumer Health Advice Source Type: news

Horizon scanning: Submission of albiglutide to the US FDA for the treatment of type 2 Diabetes
Source: PharmaLive Area: News According to a Pharmalive report, a regulatory submission has been made to the US Food and Drug Administration (US FDA) for albiglutide, an investigational biological drug that is being investigated for once-weekly treatment of adult patients with type 2 diabetes. Albiglutide is not yet approved as a treatment for type 2 diabetes or any other indication anywhere in the world. GSK intends to submit a regulatory application in the European Union (EU) in early 2013.
Source: NeLM - News - January 15, 2013 Category: Drugs & Pharmacology Source Type: news

SMC accepts dapagliflozin (ForxigaT) for restricted use in adults patients with type 2 diabetes mellitus
Source: Scottish Medicines Consortium (SMC) Area: Evidence > Drug Specific Reviews The Scottish Medicines Consortium has accepted dapagliflozin (ForxigaT) for restricted use within NHS Scotland in adults patients with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control. The SMC states that dapagliflozin is restricted to use as dual therapy in combination with metformin, when metformin alone with diet and exercise does not provide adequate g...
Source: NeLM - Drug Specific Reviews - January 15, 2013 Category: Drugs & Pharmacology Source Type: news

SMC accepts vildagliptin (GalvusT) for restricted use in patients with type 2 diabetes mellitus
Source: Scottish Medicines Consortium (SMC) Area: Evidence > Drug Specific Reviews The Scottish Medicines Consortium has accepted vildagliptin (GalvusT) for restricted use within NHS Scotland in adults with type 2 diabetes mellitus who are inadequately controlled by diet and exercise alone and for whom metformin and sulphonylureas are inappropriate due to contraindications or intolerance. The drug advice (see link below) summarises the safety and efficacy data considered for this drug in this indication. This notes that in two comparator controlled studies the non-inferiority of vildagliptin to first-...
Source: NeLM - Drug Specific Reviews - January 15, 2013 Category: Drugs & Pharmacology Source Type: news

Diabetes Screens May Not Help Heart Long Term (CME/CE)
(MedPage Today) -- Whether diabetes screening at routine primary care visits will ultimately improve cardiovascular outcomes for patients remains unclear, based on results of a prospective study.
Source: MedPage Today Cardiovascular - January 14, 2013 Category: Cardiology Source Type: news

US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos...
The US Drug Watchdog is now saying, "We fear most diabetics, who used the diabetes drug called Actos, and then developed bladder cancer will never get compensated, so we are asking family members...(PRWeb January 14, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10313854.htm
Source: PRWeb: Medical Pharmaceuticals - January 14, 2013 Category: Pharmaceuticals Source Type: news

BioPharm Insight publishes Diabetes Report for 2013
Merck, BMS, AstraZeneca, Novartis, J&J, Lilly and Boehringer among antidiabetic makers exposed to 2013 price erosion in Europe, triggered by Germany(PRWeb January 14, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10304361.htm
Source: PRWeb: Medical Pharmaceuticals - January 14, 2013 Category: Pharmaceuticals Source Type: news

Continuous Glucose Monitoring: Navigator Beats Rival DevicesContinuous Glucose Monitoring: Navigator Beats Rival Devices
A unique, but small, head-to-head-to-head trial of 3 continuous glucose-monitoring devices for diabetes showed one outperformed its rivals. But an expert says other factors need to be considered. Medscape Medical News
Source: Medscape Today Headlines - January 14, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Should Foods with High Fructose Corn Syrup Carry Warning Labels?
(HealthCastle.com) A recent study from the University of Southern California and the University of Oxford found that countries with high fructose corn syrup in their food supply have a higher prevalence of Type 2 diabetes. With that in mind, should we start labeling food products that contain high fructose corn syrup? read more
Source: HealthCastle.com Nutrition Tips - written by Registered Dietitians - January 14, 2013 Category: Nutrition Source Type: news

Uganda: Insulin 'Handshake' May Do Away With Injections - Study
[New Vision]Sydney -Australian scientists have discovered how insulin is taken up by cells, potentially opening the way for new drugs for diabetes patients that can be administered without injection.
Source: AllAfrica News: Health and Medicine - January 14, 2013 Category: African Health Source Type: news

Research scrambles previous findings on health impact of eggs
Increased egg consumption is not associated with a higher risk for coronary heart disease or stroke in the general population, research suggests.
Source: MedWire News - Diabetes - January 14, 2013 Category: Endocrinology Source Type: news

Childhood Obesity Linked to More Immediate Health Problems Than Previously Thought
January 13, 2013 (Newswise) — While a great deal of research on childhood obesity has spotlighted the long-term health problems that emerge in adulthood, a new UCLA study focuses on the condition's immediate consequences and shows that obese youngsters are at far greater risk than had been supposed. read more
Source: Diabetes News from dLife.com - January 14, 2013 Category: Consumer Health News Authors: dlife Source Type: news

Does the 5:2 intermittent fasting diet work?
Conclusion Despite being one of the most discussed of all health topics, evidence on the optimal diet is limited and dietary advice evolves slowly over time. The gold standards of evidence-based medicine – the randomised control trial – are difficult to use to assess which type of diet is best. This is due to ‘compliance’ issues. You can ‘control’ whether a person is given a dummy pill or an active medication. You cannot control what and how much they eat in the same way. So it is not surprising that the evidence base for intermittent fasting is limited. Due to the absence of evidence (though, not necessarily, ...
Source: NHS News Feed - January 14, 2013 Category: Consumer Health News Tags: Lifestyle/exercise QA articles Special reports Source Type: news

GSK Announces Submission of Albiglutide BLA to the US FDA for the Treatment of Type 2 Diabetes
GlaxoSmithKline (GSK) plc today announced a regulatory submission to the US Food and Drug Administration (US FDA) for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes. Albiglutide is not yet approved...
Source: Drugs.com - New Drug Applications - January 14, 2013 Category: Drugs & Pharmacology Source Type: news

Royal Society Medals, Awards & Prize lectures
Nominations for the Royal Society's long and distinguished portfolio of awards recognising outstanding achievements across the sciences are welcomed until 8 February 2013. To submit a nomination for one of the many prestigious Medals, Awards & Prize lectures that the Royal Society offers, please follow the link below. Royal Society Medals, Awards & Prize lectures
Source: Society for Endocrinology - January 14, 2013 Category: Endocrinology Source Type: news

The Endocrinologist (106) now online
The latest issue of our quarterly newsletter The Endocrinologist is now online. In the Winter 2012/13 issue we discuss recently published research on the proportion of diabetes & endocrinology trainees securing consultant posts, we introduce two new features on hot new techniques and pet hormones, and we bring you all the latest news from SfE's activities in the public, clinical and scientific arenas. You can access the issue for free via the link below. The Endocrinologist 106
Source: Society for Endocrinology - January 14, 2013 Category: Endocrinology Source Type: news

GSK files for U.S. approval of new diabetes drug
LONDON (Reuters) - GlaxoSmithKline said on Monday it had filed for U.S. approval of its new once-weekly diabetes drug albiglutide and would make a similar submission shortly in Europe as it vies for a share of a crowded market.
Source: Reuters: Health - January 14, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Regulatory update – GSK announces submission of albiglutide BLA to the US FDA for the treatment of type 2 diabetes
Source: GSK news - January 14, 2013 Category: Pharmaceuticals Source Type: news

Body shape stories fail to kill off myths
Conclusion This study was a well-conducted cross-sectional study that has been over-interpreted by the media. This was not a study that aimed to compare women with different distributions of body fat and their risk of developing heart disease. The study has its strengths, in that it was carefully conducted and designed to test and describe a particular link of scientific interest. However, it is hard to see how the design or results can say anything about the risk of diabetes or vascular disease in women who are apple-shaped (fat distributed around the waist) compared with those who are pear-shaped (fat distributed around ...
Source: NHS News Feed - January 14, 2013 Category: Consumer Health News Tags: Food/diet Heart/lungs Source Type: news

Claims body shape myths 'overturned' exaggerated
Conclusion This study was a well-conducted cross-sectional study that has been over-interpreted by the media. This was not a study that aimed to compare women with different distributions of body fat and their risk of developing heart disease. The study has its strengths, in that it was carefully conducted and designed to test and describe a particular link of scientific interest. However, it is hard to see how the design or results can say anything about the risk of diabetes or vascular disease in women who are apple-shaped (fat distributed around the waist) compared with those who are pear-shaped (fat distributed around ...
Source: NHS News Feed - January 14, 2013 Category: Consumer Health News Tags: Food/diet Heart/lungs Source Type: news

Lower Liver Quality From Donation After Cardiac Death Linked To Decline In Livers Available For Transplant
A new study, funded in part by the National Institutes of Health (NIH) and Health Resources and Services Administration, and published in the January 2013 issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases (AASLD), found that the non-use of donor livers climbed through 2010 due to a worsening of donor liver quality, primarily from donation following cardiac death. Diabetes, donor age, and body mass index (BMI) were also linked to a decrease in use of organs...
Source: Health News from Medical News Today - January 14, 2013 Category: Consumer Health News Tags: Transplants / Organ Donations Source Type: news

Study Questions Notion That Bodies That Are Pear-Shaped Are Healthier Than Apple-Shaped
People who are "apple-shaped" - with fat more concentrated around the abdomen - have long been considered more at risk for conditions such as heart disease and diabetes than those who are "pear-shaped" and carry weight more in the buttocks, hips and thighs. But new research conducted at UC Davis Health System published in The Journal of Clinical Endocrinology and Metabolism provides further evidence that the protective benefits of having a pear-body shape may be more myth than reality. The journal article is posted online and will appear in the March 2013 print edition...
Source: Health News from Medical News Today - January 14, 2013 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Overcome diabetes with these powerful therapeutic herbs
If you or someone you know suffers from either diabetes or pre-diabetes, it might come as a surprise to learn that a life of endless insulin shots and blood glucose drugs is not your only treatment option. If you are serious about truly overcoming your diabetic condition...
Source: NaturalNews.com - January 14, 2013 Category: Consumer Health Advice Source Type: news

Horizon scanning: US FDA panel recommends approval of canagliflozin for type 2 diabetes
Source: BioSpace Area: News According to BioSpace, the Endocrinologic and Metabolic Drugs Advisory Committee of the US FDA has voted 10-5 to recommend the approval of canagliflozin for the treatment of type 2 diabetes in adults. Canagliflozin is a selective sodium glucose co-transporter 2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose by the kidney, thus increasing glucose excretion and lowering blood glucose levels. People with type 2 diabetes reabsorb greater amounts of glucose than those without diabetes, and this may contribute to elevated glucose levels. The advisory committee ...
Source: NeLM - News - January 14, 2013 Category: Drugs & Pharmacology Source Type: news

30 Days to Better Sleep: Decrease the Frequency of Trips to the Bathroom to Pee
<p><img class="alignnone" src="http://0.tqn.com/h/sleepdisorders/1/9/x/0/-/-/BW_Nightstand.jpg" alt="Getty Images" /></p> <p>There is nothing worse than having to wake up in the middle of the night to go to the bathroom. Once you get to sleep, the last thing you need is a full bladder waking you up. For some people, these awakenings may even evolve into difficulty falling back asleep, a symptom of <a href="http://clk.about.com/?zi=1/1hc&zu=http://sleepdisorders.about.com/od/commonsleepdisorders/a/What_Is_Insomnia.htm">insomnia</a>. How can you decrease the number of tri...
Source: About Sleep Disorders - January 14, 2013 Category: Sleep Medicine Source Type: news

Certain Cells May Help Diabetics
(Ivanhoe Newswire) – Most people know at least a little bit about diabetes, and with the occurrence of type-two diabetes rising in the United States, the disease could become an even more health common topic. Thankfully, awareness about diabetes is not the only thing on the rise; treatments and even possible cures are also highly sought after in the scientific and medical community.
Source: Medical Headlines From Ivanhoe.com - January 14, 2013 Category: Consumer Health News Source Type: news

Mild Gestational DiabetesMild Gestational Diabetes
Should women with mild gestational diabetes mellitus be treated or observed? Expert Review of Endocrinology and Metabolism
Source: Medscape Diabetes Headlines - January 13, 2013 Category: Endocrinology Tags: Diabetes & Endocrinology Journal Article Source Type: news

Eplerenone on PTH Levels in Primary HyperparathyroidismEplerenone on PTH Levels in Primary Hyperparathyroidism
Can this mineralocorticoid receptor antagonist reduce PTH secretion? BMC Endocrine Disorders
Source: Medscape Today Headlines - January 13, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

GSK files type 2 diabetes drug for FDA approval
GlaxoSmithKline has submitted albiglutide, an investigational drug for the treatment of type 2 diabetes, to the US Food and Drug Administration for approval.
Source: Pharmaceutical Technology - January 13, 2013 Category: Pharmaceuticals Source Type: news